ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LIVN Livanova

50.00
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Livanova LSE:LIVN London Ordinary Share GB00BYMT0J19 ORD GBP1.00 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 50.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

LivaNova to Host Conference Call for First Quarter 2017 Results

29/03/2017 4:00pm

Business Wire


Livanova (LSE:LIVN)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Livanova Charts.

LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, will host a conference call to discuss its first quarter results on Wednesday, May 3, 2017 at 8 a.m. Central Daylight Time (1 p.m. GMT; 2 p.m. BST).

The Company will release its first quarter results earlier that morning, before the open of the U.S. financial markets.

A live webcast of the conference call will be available on the Investor Relations section of LivaNova’s website at www.LivaNova.com. To listen to the conference call by telephone, dial 844-239-5285 (if dialing from within the U.S.) or 512-961-6524 (if dialing from outside the U.S.). The conference ID is 94170935. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the webcast. A replay will be available on the LivaNova website for 90 days following the call.

About LivaNova

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. LivaNova’s advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. Headquartered in London and with a presence in more than 100 countries worldwide, the company employs more than 4,500 employees. LivaNova operates as three business franchises: Cardiac Surgery, Neuromodulation and Cardiac Rhythm Management, with operating headquarters in Mirandola (Italy), Houston (U.S.A.) and Clamart (France), respectively.

For more information, please visit www.LivaNova.com.

LivaNova PLC Investor Relations and MediaKaren King, +1 (281) 228-7262Vice President, Investor Relations & Corporate CommunicationsorDeanna Wilke, +1 (281) 727-2764Corporate External Communications ManagerCorporate.Communications@LivaNova.com

1 Year Livanova Chart

1 Year Livanova Chart

1 Month Livanova Chart

1 Month Livanova Chart

Your Recent History

Delayed Upgrade Clock